Missailidis S - Search Results

1

Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties.

Alcaro S, Artese A, Iley JN, Missailidis S, Ortuso F, Parrotta L, Pasceri R, Paduano F, Sissi C, Trapasso F, Vigorita MG. Alcaro S, et al. Among authors: missailidis s. ChemMedChem. 2010 Apr 6;5(4):575-83. doi: 10.1002/cmdc.200900541. ChemMedChem. 2010. PMID: 20135671

2

Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold.

Alcaro S, Artese A, Iley JN, Maccari R, Missailidis S, Ortuso F, Ottanà R, Ragazzon P, Vigorita MG. Alcaro S, et al. Among authors: missailidis s. Bioorg Med Chem Lett. 2007 May 1;17(9):2509-14. doi: 10.1016/j.bmcl.2007.02.022. Epub 2007 Feb 9. Bioorg Med Chem Lett. 2007. PMID: 17317164

3

Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.

Cheng MK, Modi C, Cookson JC, Hutchinson I, Heald RA, McCarroll AJ, Missailidis S, Tanious F, Wilson WD, Mergny JL, Laughton CA, Stevens MF. Cheng MK, et al. Among authors: missailidis s. J Med Chem. 2008 Feb 28;51(4):963-75. doi: 10.1021/jm070587t. Epub 2008 Feb 2. J Med Chem. 2008. PMID: 18247546

4

Structure-activity studies of the binding of the flavonoid scaffold to DNA.

Ragazzon PA, Iley J, Missailidis S. Ragazzon PA, et al. Among authors: missailidis s. Anticancer Res. 2009 Jun;29(6):2285-93. Anticancer Res. 2009. PMID: 19528493 Free article.

5

The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development.

Ragazzon PA, Bradshaw T, Matthews C, Iley J, Missailidis S. Ragazzon PA, et al. Among authors: missailidis s. Anticancer Res. 2009 Jun;29(6):2273-83. Anticancer Res. 2009. PMID: 19528492 Free article.

6

Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.

Missailidis S, Stanslas J, Modi C, Ellis MJ, Robins RA, Laughton CA, Stevens MF. Missailidis S, et al. Oncol Res. 2002;13(3):175-89. Oncol Res. 2002. PMID: 12549627

7

Antitumor polycyclic acridines. Part 16. Triplex DNA as a target for DNA-binding polycyclic acridine derivatives.

Missailidis S, Modi C, Trapani V, Laughton CA, Stevens MF. Missailidis S, et al. Oncol Res. 2005;15(2):95-105. Oncol Res. 2005. PMID: 16119007

8

Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivatives.

Giménez-Arnau E, Missailidis S, Stevens MF. Giménez-Arnau E, et al. Among authors: missailidis s. Anticancer Drug Des. 1998 Mar;13(2):125-43. Anticancer Drug Des. 1998. PMID: 9524555

9

Antitumour polycyclic acridines. Part 4. Physico-chemical studies on the interactions between DNA and novel tetracyclic acridine derivatives.

Giménez-Arnau E, Missailidis S, Stevens MF. Giménez-Arnau E, et al. Among authors: missailidis s. Anticancer Drug Des. 1998 Jul;13(5):431-51. Anticancer Drug Des. 1998. PMID: 9702209

10

Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling.

Bostock-Smith CE, Giménez-Arnau E, Missailidis S, Laughton CA, Stevens MF, Searle MS. Bostock-Smith CE, et al. Among authors: missailidis s. Biochemistry. 1999 May 25;38(21):6723-31. doi: 10.1021/bi9825807. Biochemistry. 1999. PMID: 10346892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters